Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy

NCT00183950 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped No funding

Conditions

Non-Hodgkin's Lymphoma
Chronic Lymphocytic Leukemia

Interventions

DRUG: Noscapine

Sponsor

University of Southern California